Invicare Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
Invicare General Information
Description
Developer of nanocrystalline biomaterials designed to prevent and treat dental implant infections. The company offers biomaterials that provide dental implant cleaning, infection prevention, and infection treatment capabilities using proprietary inorganic crystalline hydrogels, enabling dental professionals to improve implant care and support better treatment outcomes.
Contact Information
Website
www.invicare.caCorporate Office
- 1250 Rue Guy
- Suite 600
- Montreal, Quebec H3H 2R7
- Canada
Corporate Office
- 1250 Rue Guy
- Suite 600
- Montreal, Quebec H3H 2R7
- Canada
Invicare Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 23-Jun-2021 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 6. Angel (individual) | 01-Feb-2021 | Completed | Generating Revenue | |||
| 5. Angel (individual) | 11-Oct-2018 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 27-Feb-2017 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2017 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Invicare Patents
Invicare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024082070-A1 | Bone implant with a magnesium phosphate xerogel coating | Inactive | 21-Oct-2022 | ||
| EP-3386547-A1 | Magnesium phosphate hydrogels | Active | 10-Dec-2015 | ||
| EP-3386547-A4 | Magnesium phosphate hydrogels | Active | 10-Dec-2015 | ||
| EP-3386547-B1 | Magnesium phosphate hydrogels | Active | 10-Dec-2015 | ||
| EP-4104864-A1 | Magnesium phosphate hydrogels | Active | 10-Dec-2015 | C01B25/45 |
Invicare Signals
Invicare Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Medical Alley Association | Accelerator/Incubator | Minority | ||
| Centech Accelerator | Accelerator/Incubator | |||
| McGill Dobson Centre for Entrepreneurship | Accelerator/Incubator | Minority | ||
| McGill X-1 Accelerator | Accelerator/Incubator | |||
| McGill University | University |
Invicare FAQs
-
When was Invicare founded?
Invicare was founded in 2017.
-
Where is Invicare headquartered?
Invicare is headquartered in Montreal, Canada.
-
What is the size of Invicare?
Invicare has 3 total employees.
-
What industry is Invicare in?
Invicare’s primary industry is Biotechnology.
-
Is Invicare a private or public company?
Invicare is a Private company.
-
What is Invicare’s current revenue?
The current revenue for Invicare is .
-
Who are Invicare’s investors?
Medical Alley Association, Centech Accelerator, McGill Dobson Centre for Entrepreneurship, McGill X-1 Accelerator, and McGill University are 5 of 6 investors who have invested in Invicare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process